Skip to content

Changing lives forever

At Celosia Therapeutics, we are modifying the neuronal microenvironment to defeat neurodegenerative disease.

Learn More

About

We Develop Solutions For Neurodegenerative Diseases With No Therapeutic Options.

Developing effective treatments for neurodegenerative diseases is challenging and despite recent advances, many people living with neurodegenerative diseases continue to have limited therapeutic options and an overall poor prognosis. Celosia Therapeutics approach arises from advances in gene therapies, and greater understanding of the molecular pathways contributing to neurodegenerative diseases.

Neurodegenerative diseases we are working on:

  • ALS/MND/LGD
  • Alzheimer’s disease
  • Fronto-temporal dementia
  • Dravet Syndrome

Our Team

We are scientists, clinicians, innovators, and entrepreneurs redefining the treatment landscape for individuals with devastating neurodegenerative diseases.

Celosia in the News

Contact Us for Media Inquiries at media@celosiatx.com

Uncategorised

Video – Interview with Mr Iomar Barrett

Posted on by ksunn

Mr Iomar Barrett, Celosia Therapeutics’ Series A investor and hedge fund manager, speaks about…

Uncategorised

Video – Interview with Prof Lars Ittner and Prof Yazi Ke

Posted on by ksunn

In this video, Celosia Therapeutics co-founders Professor Lars Ittner and Professor Yazi Ke speak ab…

Uncategorised

Video – Interview with Celosia Therapeutics CEO Dr Kathryn Sunn

Posted on by ksunn

Celosia Therapeutics CEO and Director of Commercialisation at Macquarie University, Dr Kathryn Sunn …

Uncategorised

Celosia Secures Landmark $16.75M Funding for Breakthrough ALS Gene Therapy

Posted on by ksunn

Sydney, Australia, 28 November 2024 – Celosia Therapeutics, an Australian biotech company developing…

Uncategorised

New Research Publication

Posted on by bhamdorf

Published online (16th Feb 2024) in the prestigious journal Neuron is the outcome of over 15 years o…

Uncategorised

Celosia Therapeutics Launch

Posted on by bhamdorf

Macquarie University announces the launch of a new company, Celosia Therapeutics, dedicated to deliv…

View all News